List of All Articles with Tag 'son'

Ferrari team principal Fred Vasseur has slammed the FIA and labelled Red Bull’s penalty last year for breaching the cost cap as a “big joke.” Red Bull, who have won the drivers’ title in the last two years and are on track to do so with Max Verstappen again this year, were found guilty of a minor financial overspend for 2021 and were handed a £6m fine and docked 10 per cent of their car development time. However, the penalty has had little impact on Red Bull’s progress having won all 12 races so far this year – and Christian Horner’s team have won 22 of the last 23 grands prix overall. Ex-Alfa Romeo chief Vasseur, who took over at Ferrari from Mattia Binotto before the start of this season, insists the punishment should have been a lot harsher on Red Bull. "A penalty like last year really isn’t severe. If it should be necessary again, such a penalty should be much heavier,” the Frenchman told Italian outlet La Gazzetta dello Sport. "You have to keep in mind that a technical advantage will translate into a sporting advantage. Therefore, the penalty should be sporting and not a fine. “In soccer, if you use a hand, it’s a penalty... they don’t give you a [non-sporting] penalty. “The deduction of 10 per cent wind tunnel time is a big joke. They have already done most of the work by then." Verstappen is currently on a win-streak of eight and can match Sebastian Vettel’s all-time record from 2013 of nine with victory at his home race next up in Zandvoort. Ferrari, meanwhile, have not won a race since Austria last year and are currently fourth in the Constructors’ Championship behind Red Bull, Mercedes and Aston Martin. F1 returns after the summer break next week with the Dutch Grand Prix (25-27 August). Read More F1 2023 mid-season awards: Best driver, worst race and biggest surprise Carlos Sainz interview: ‘All of us at Ferrari expected more – we haven’t done the best job’ ‘It was pretty wild’: F1 champion Max Verstappen learns how to drift ‘It was pretty wild’: F1 champion Max Verstappen learns how to drift ‘Incredible’ Norris backed for more podium success by Verstappen and Perez F1 2023 calendar: All 23 Grand Prix this year

China's economy is in trouble. That's bad news for US stocks, and potentially for your portfolio.

By Kane Wu and Abigail Summerville HONG KONG/NEW YORK U.S. meat and processed food maker Tyson Foods plans

NBA star James Harden expressed disbelief after Chinese fans snapped up 10,000 bottles of his own-branded wine in seconds, demonstrating the massive reach of livestreaming in the country, where basketball is loved by millions.

The World Health Organization holds its first summit on traditional medicine on Thursday, with warnings that treatments rooted in natural products can be effective alternative...

The special counsel investigating Donald Trump for his role in the January 6 storming of

A central Florida art museum that was raided last year by the FBI over an exhibit of what turned out to be forged Jean-Michel Basquiat paintings has sued its former executive director and others, claiming they were part of a scheme to profit from the sale of the fake artwork

Historians were struck by the tantalizing possibility that this library might contain missing works of some of history’s greatest writers—works thought to have been lost forever.

Adriana Cisneros has been obsessed with satellites ever since she was a child in Venezuela. Now, after a

(Reuters) -Walmart Inc on Wednesday named Sam's Club Chief Executive Kathryn McLay as new head of its international division, succeeding

By Brendan Pierson Access to the abortion pill mifepristone must be restricted, a U.S. appeals court ruled on

A high-stakes lawsuit over the future of a widely used abortion drug is likely heading to the US Supreme Court, set to determine the fate of abortion rights access across the country for a second time within two years. Three Republican-appointed judges on a federal appeals court have determined that the federal government did not follow proper procedures when it amended regulations for a commonly used medication abortion drug in 2016. But the restrictions will not immediately take effect. The panel partially upheld a ruling from a Donald Trump-appointed federal judge in Texas, whose sweeping decision earlier this year threatened to strip access to the drug altogether. Nothing in the ruling from a three-judge panel on 16 August will go into effect until the nation’s highest court weighs in. Wednesday’s ruling argues that the US Food and Drug Administration unlawfully expanded access to mifepristone, which was first approved by the federal government more than 20 years ago. Mifepristone was first approved by the FDA in 2000 and is approved for use up to 10 weeks of pregnancy. A vast majority of abortions occur within the first nine weeks of pregnancy. From 2019 through 2020, nearly 93 per cent of all abortions were performed before the 13th week, according to the US Centers for Disease Control and Prevention. The drug – part of a two-drug protocol for medication abortions, the most common form of abortion care in the US – is the subject of a lawsuit from a group of anti-abortion activists represented by right-wing Christian legal group Alliance Defending Freedom, which joined efforts to overturn Roe v Wade at the Supreme Court last year. In April, US District Judge Matthew Kacsmaryk – a former right-wing activist lawyer who was appointed to the federal judiciary by Mr Trump – issued a ruling to suspend the FDA’s approval, which was immediately challenged by abortion rights advocates, providers, major medical groups, drug manufacturers and President Joe Biden’s administration. An initial ruling at the US Court of Appeals for the Fifth Circuit blocked part of that decision but struck down policies for mail-in prescriptions and rules that expanded the drug’s approval for pregnancies up to 10 weeks. On 21 April, the Supreme Court blocked the lower courts’ rulings from taking effect while the case plays out, retaining the status quo while the legal case plays out. Following the Supreme Court’s conservative supermajority decision to revoke a constitutional right to abortion care in Dobbs v Jackson Women’s Health Organization, at least 15 states – mostly across the US South – have effectively banned most abortions and imposed criminal penalties against providers. Abortion rights advocates and providers have warned that eliminating or restricting access to mifepristone could drastically impact an already-fragile landscape for abortion care. A ruling that undermines the FDA’s drug approval process could also open the door for other activist-driven legal battles over other drugs wrapped up in political debates, potentially inviting other destabilising lawsuits to Covid-19 vaccines, contraception, HIV medication, gender-affirming care, and other life-saving drugs. Read More What is mifepristone? The widely used pill in the abortion rights battle at the Supreme Court Abortion rights advocates win major victory in Ohio as voters reject GOP plan to thwart ballot measure Texas women detailed agonising pregnancies after being denied abortions. The state blames doctors Some abortion drug restrictions upheld by in a case bound for Supreme Court Akram criticizes Pakistan Cricket Board for leaving Imran Khan out of Independence Day video Netanyahu voices support for Israel's military after his allies and son lambaste security officials